You are currently viewing a new version of our website. To view the old version click .

Pathophysiology, Diagnosis and Novel Treatment of Obstructive Lung Diseases

This special issue belongs to the section “Respiratory Medicine“.

Special Issue Information

Dear Colleagues,

Even though recent progress of scientific knowledge and the availability of new therapeutic and diagnostic tools have improved the management of obstructive diseases such as asthma and chronic obstructive pulmonary disease (COPD), they remain a foremost public health problem and a challenge for physicians.

As a consequence, asthma and COPD are currently hot topics, as their high prevalence, morbidity, and mortality create many clinical challenges. In this Special Issue, we pursue original research studies and reviews that provide added value to the knowledge of clinicians on the management of asthma and COPD, from epidemiological, diagnostic, and therapeutic points of view, especially on novel treatments. Moreover, we are particularly interested in studies from countries which have not traditionally been represented in the previous publications. We are also keen to receive articles dealing with the pathophysiological pathways connecting asthma and COPD to comorbidities. Human studies and experimental animal and cell culture models are equally encouraged. In addition, aspirant authors are encouraged to submit the results of clinical trials.

Dr. Andras Bikov
Prof. Silvano Dragonieri
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • asthma
  • COPD
  • obstructive diseases
  • novel treatments

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
J. Clin. Med. - ISSN 2077-0383